Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicenter, Randomized-Controlled Study to Evaluate the Safety and Efficacy of Autologous Incubated Macrophages for the Treatment of Patients With Complete Spinal Cord Injuries

NCT00073853 is registered in ClinicalTrials.gov with Proneuron Biotechnologies as lead sponsor.

NCT NCT00073853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00073853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicenter, Randomized-Controlled Study to Evaluate the Safety and Efficacy of Autologous Incubated Macrophages for the Treatment of Patients With Complete Spinal Cord Injuries
Lead sponsor
Proneuron Biotechnologies
Phase
Phase 2
Overall status
Suspended
Start date
September 30, 2003
Completion date
Not reported
Enrollment
61
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury